U.S. Chamber of Commerce Challenges Federal Government’s New Drug-Price Powers
The lawsuit is the second filed this week saying Medicare’s new negotiating authority is unconstitutional. Source link
The lawsuit is the second filed this week saying Medicare’s new negotiating authority is unconstitutional. Source link
The drugmaker filed a lawsuit saying Medicare’s drug-price negotiation program violates the company’s constitutional rights. Source link
An mRNA shot helped prevent relapse in high-risk melanoma patients. Source link
Demand for its Covid-19 vaccine sank from year-earlier highs when the spread of the Omicron variant boosted sales. Source link
HealthDoctors, pharmacists ask the FDA to stop the sale of versions of Benadryl, Mucinex, Theraflu and Tylenol after studies find...
BusinessThe U.S. biotechnology company will pay $116.50 for each Horizon share Source link
HealthRivals’ interest in the $7 billion market shows the drug industry’s renewed focus on vaccines Source link
Pfizer Inc. PFE -1.18% is in advanced talks to buy Global Blood Therapeutics Inc., GBT 33.03% the maker of a...
Merck & Co.’s roughly $40 billion deal for Seagen Inc. is unlikely to be finalized ahead of the pharmaceutical giant’s...
Merck MRK -0.32% & Co. is eyeing a purchase of biotech Seagen Inc., SGEN 12.72% according to people familiar with...
The first Covid-19 antiviral pills that can be taken at home are a new treatment option for infected people, but...
U.S. regulators cleared use of a Covid-19 pill from Merck MRK -0.33% & Co. and partner Ridgeback Biotherapeutics LP, the...
U.S. health regulators cleared use of a Covid-19 pill from Pfizer Inc., the first drug that newly infected patients can...
Pfizer Inc. said it asked U.S. health regulators to authorize its oral Covid-19 drug for use in high-risk patients, putting...
Merck & Co. will license a promising Covid-19 drug to a United Nations-backed nonprofit to provide more supplies to low-...
Merck & Co. and partner Ridgeback Biotherapeutics LP said Monday they have filed an application asking U.S. health regulators to...
Corporate giants from Apple Inc. to Visa Inc. are expected to report their financial results over the coming week, giving...
WASHINGTON—The Biden administration will invest more than $3 billion on developing and manufacturing antiviral pills to treat coronavirus, the Department...
The Wall Street Journal is hosting its CEO Council summit Tuesday with top executives, administration officials and policy experts, as...
An experimental Covid-19 drug that promises to be a kind of Tamiflu for the pandemic had positive results in a...